Acute leukaemia types: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
Line 17: | Line 17: | ||
|colspan="1" style = "font-size:84%;"|Frequently expressed, most often in less differentiated forms of AML. Expression often less intense than in lymphoid leukaemias | |colspan="1" style = "font-size:84%;"|Frequently expressed, most often in less differentiated forms of AML. Expression often less intense than in lymphoid leukaemias | ||
|- | |- | ||
|colspan="1" style = "width: 4%; font-size:90%; color:black;" |'''[[ | |colspan="1" style = "width: 4%; font-size:90%; color:black;" |'''[[TDT]]''' | ||
|colspan="1" style = "width: 8%; background:#00b8e6;"| | |colspan="1" style = "width: 8%; background:#00b8e6;"| | ||
|colspan="1" style = "font-size:80%;"|Expressed particularly in less differentiated forms of AML. Often on a sub-population of cells; expression usually less intense than in lymphoid leukaemias | |colspan="1" style = "font-size:80%;"|Expressed particularly in less differentiated forms of AML. Often on a sub-population of cells; expression usually less intense than in lymphoid leukaemias |
Revision as of 12:28, 17 July 2023
Marker patterns in typical acute myeloid leukaemia | |||
---|---|---|---|
CD45 expression in AML | |||
Weak expression of CD45 is "weak" i.e. significantly less intense than normal T cells, B cells or monocytes. The typically low side scatter means that myeloid blast cells tend to form a relatively uniform population on CD45/SSc plots. However, there is some variability releted to indididual subtypes. | |||
Markers of pimitive cell type expected in AML | |||
Marker | Expectation | Comment | |
CD34 | Frequently expressed, most often in less differentiated forms of AML. Expression often less intense than in lymphoid leukaemias | ||
TDT | Expressed particularly in less differentiated forms of AML. Often on a sub-population of cells; expression usually less intense than in lymphoid leukaemias | ||
CD7 | Similar to TdT, CD7 expression is recognised on a proportion of AML, usually those with less differentaited phenotype |